{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:01:34Z","timestamp":1761919294932},"reference-count":128,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2010,1,19]],"date-time":"2010-01-19T00:00:00Z","timestamp":1263859200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2010,4]]},"abstract":"<jats:sec><jats:label\/><jats:p> <jats:italic>Aliment Pharmacol Ther<\/jats:italic>\u2002<jats:bold>31<\/jats:bold>, 771\u2013787<\/jats:p><\/jats:sec><jats:sec><jats:title>Summary<\/jats:title><jats:p><jats:bold>Background\u2002<\/jats:bold> The management of autoimmune hepatitis (AIH) continues to be refined. However, several issues remain unresolved, primarily as a consequence of the low incidence of the disease. This factor has contributed both to a lack of understanding of and a paucity of large scale clinical trials involving therapeutic agents.<\/jats:p><jats:p><jats:bold>Aim\u2002<\/jats:bold> To summarize the latest evidence regarding the pathogenesis, diagnosis, therapy and long\u2010term management of AIH with a focus on clinical aspects of the disease.<\/jats:p><jats:p><jats:bold>Method\u2002<\/jats:bold> We searched PUBMED for articles pertaining to AIH, its pathogenesis, treatment and clinical outcomes, combined with the authors\u2019 own knowledge of the literature.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> Standard therapy (corticosteroids and azathioprine) is effective in more than 80% of patients which renders study of novel agents difficult. Budesonide appears to show equivalence to prednisolone. Available, but limited, data suggest that mycophenolate mofetil, tacrolimus and ciclosporin are all variably effective second line agents. Patients with AIH and cirrhosis are at risk of hepatocellular carcinoma (HCC) and require screening. Patients with end stage liver disease represent excellent candidates for liver transplantation.<\/jats:p><jats:p><jats:bold>Conclusions\u2002<\/jats:bold> Despite ongoing limitations in the understanding of pathogenesis and difficulties in evaluating novel therapies, the management of AIH continues to evolve slowly. Multi\u2010centre collaboration is necessary to obtain sufficient patient numbers to undertake good quality therapeutic studies.<\/jats:p><\/jats:sec>","DOI":"10.1111\/j.1365-2036.2010.04241.x","type":"journal-article","created":{"date-parts":[[2010,1,20]],"date-time":"2010-01-20T01:55:25Z","timestamp":1263952525000},"page":"771-787","source":"Crossref","is-referenced-by-count":46,"title":["Review article: the modern management of autoimmune hepatitis"],"prefix":"10.1111","volume":"31","author":[{"given":"A. D.","family":"YEOMAN","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. S.","family":"LONGHI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. A.","family":"HENEGHAN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,3,17]]},"reference":[{"key":"e_1_2_14_2_2","doi-asserted-by":"publisher","DOI":"10.1080\/00365529850166284"},{"key":"e_1_2_14_3_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20804"},{"key":"e_1_2_14_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)92858-Y"},{"key":"e_1_2_14_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)62476-2"},{"key":"e_1_2_14_6_2","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3109\/00365529709007689","article-title":"Detection of antibodies to hepatitis E virus in patients with autoimmune chronic active hepatitis and primary biliary cirrhosis","volume":"32","author":"Le Cann P","year":"1997","journal-title":"Scand J Gastroenterol"},{"key":"e_1_2_14_7_2","first-page":"2618","article-title":"Autoimmune hepatitis type 1 after measles","volume":"91","author":"Vento S","year":"1996","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_14_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)91438-2"},{"key":"e_1_2_14_9_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.312.7024.169"},{"key":"e_1_2_14_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01316809"},{"key":"e_1_2_14_11_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-200609000-00018"},{"key":"e_1_2_14_12_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2003.031732"},{"key":"e_1_2_14_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840190311"},{"key":"e_1_2_14_14_2","first-page":"1206","article-title":"The validity and importance of subtypes in autoimmune hepatitis: a point of view","volume":"90","author":"Czaja AJ","year":"1995","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_14_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(99)80297-9"},{"key":"e_1_2_14_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(87)92024-1"},{"key":"e_1_2_14_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(99)80342-0"},{"key":"e_1_2_14_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02166-8"},{"key":"e_1_2_14_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(00)80361-X"},{"key":"e_1_2_14_20_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI115443"},{"key":"e_1_2_14_21_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.170.3.1481"},{"key":"e_1_2_14_22_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198211183072102"},{"key":"e_1_2_14_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(84)91691-X"},{"key":"e_1_2_14_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2004.03.008"},{"key":"e_1_2_14_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2005.05.001"},{"key":"e_1_2_14_26_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.176.7.4484"},{"key":"e_1_2_14_27_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.21.120601.141122"},{"key":"e_1_2_14_28_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.193.11.1303"},{"key":"e_1_2_14_29_2","doi-asserted-by":"crossref","first-page":"S323","DOI":"10.1016\/S0168-8278(08)60863-6","article-title":"A complex immunoregulatory deficiency characterises type 1 autoimmune hepatitis","volume":"48","author":"Ferri S","year":"2008","journal-title":"J Hepatol"},{"key":"e_1_2_14_30_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0029-1233536"},{"key":"e_1_2_14_31_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI115836"},{"key":"e_1_2_14_32_2","first-page":"687","article-title":"A murine model of acute liver injury induced by human monoclonal antibody","volume":"40","author":"Yamauchi K","year":"2005","journal-title":"Hepatology"},{"key":"e_1_2_14_33_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2008.06.042"},{"key":"e_1_2_14_34_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840180435"},{"key":"e_1_2_14_35_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22322"},{"key":"e_1_2_14_36_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22513"},{"key":"e_1_2_14_37_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23042"},{"key":"e_1_2_14_38_2","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2002.34944"},{"key":"e_1_2_14_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2005.06.006"},{"key":"e_1_2_14_40_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2007.01153.x"},{"key":"e_1_2_14_41_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2007.01147.x"},{"key":"e_1_2_14_42_2","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0140-6736(64)91627-7","article-title":"Treatment of active chronic hepatitis and lupoid hepatitis with 6\u2010mercaptopurine and azothioprine","volume":"42","author":"Mackay IR","year":"1964","journal-title":"Lancet"},{"key":"e_1_2_14_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(19)33223-8"},{"key":"e_1_2_14_44_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.21.1.78"},{"key":"e_1_2_14_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(73)92125-9"},{"key":"e_1_2_14_46_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.qjmed.a067264"},{"key":"e_1_2_14_47_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199510123331502"},{"key":"e_1_2_14_48_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840080414"},{"key":"e_1_2_14_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(85)91329-7"},{"key":"e_1_2_14_50_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02220605"},{"key":"e_1_2_14_51_2","doi-asserted-by":"publisher","DOI":"10.1097\/00008571-199208000-00002"},{"key":"e_1_2_14_52_2","doi-asserted-by":"publisher","DOI":"10.2217\/14622416.9.3.303"},{"key":"e_1_2_14_53_2","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/95.7.439"},{"key":"e_1_2_14_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2005.07.059"},{"key":"e_1_2_14_55_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-129-9-199811010-00007"},{"key":"e_1_2_14_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2008.02.032"},{"key":"e_1_2_14_57_2","first-page":"399","article-title":"Choice of azathioprine or 6\u2010 mercaptopurine dose based on thiopurine methyltransferase (TPMT) activity to avoid myelosuppression. A prospective study","volume":"53","author":"Gisbert JP","year":"2006","journal-title":"Hepatogastroenterology"},{"key":"e_1_2_14_58_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(02)00214-3"},{"key":"e_1_2_14_59_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2006.05.011"},{"key":"e_1_2_14_60_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0266462308080392"},{"key":"e_1_2_14_61_2","unstructured":"OllierWER.A prospective randomised controlled trial of azathioprine methyltransferase (TPMT) genotyping in the management of patients prior to commencement of azathioprine. Available at:http:\/\/www.controlled\u2010trilas.com\/mrct\/trial\/238433\/azathioprine."},{"key":"e_1_2_14_62_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(00)70140-5"},{"key":"e_1_2_14_63_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-200412000-00028"},{"key":"e_1_2_14_64_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005176-200209000-00032"},{"key":"e_1_2_14_65_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.1994.tb00334.x"},{"key":"e_1_2_14_66_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2000.0010000001"},{"key":"e_1_2_14_67_2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v12.i9.1362"},{"key":"e_1_2_14_68_2","doi-asserted-by":"publisher","DOI":"10.1155\/2008\/509459"},{"key":"e_1_2_14_69_2","first-page":"630","article-title":"Deflazacort for long\u2010term maintenance of remission in type I autoimmune hepatitis","volume":"91","author":"Rebollo Bernardez J","year":"1999","journal-title":"Rev Esp Enferm Dig"},{"key":"e_1_2_14_70_2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v9.i12.2681"},{"key":"e_1_2_14_71_2","first-page":"376A","article-title":"Budesonide 3mg bid in combination with azathioprine as maintenance treatment in autoimmune hepatitis \u2010 final results of a large multicenter international trial","volume":"37","author":"Manns MP","year":"2008","journal-title":"Hepatology"},{"key":"e_1_2_14_72_2","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2002.30991"},{"key":"e_1_2_14_73_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(00)80271-8"},{"key":"e_1_2_14_74_2","doi-asserted-by":"publisher","DOI":"10.1155\/2004\/504591"},{"key":"e_1_2_14_75_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2005.01107.x"},{"key":"e_1_2_14_76_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.mcg.0000177260.72692.e8"},{"key":"e_1_2_14_77_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-008-0632-0"},{"key":"e_1_2_14_78_2","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.cgh.2008.04.006","article-title":"A single center review of the use of mycophenolate mofetil in the treatment of autoimmune hepatitis","volume":"6","author":"Inductivo\u2010Yu I","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"e_1_2_14_79_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2008.04.006"},{"key":"e_1_2_14_80_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2008.02180.x"},{"key":"e_1_2_14_81_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2009.02.024"},{"key":"e_1_2_14_82_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200012270-00010"},{"key":"e_1_2_14_83_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.TP.0000084823.89528.89"},{"key":"e_1_2_14_84_2","doi-asserted-by":"publisher","DOI":"10.1002\/lt.20810"},{"key":"e_1_2_14_85_2","first-page":"771","article-title":"Tacrolimus: a potential new treatment for autoimmune chronic active hepatitis: results of an open\u2010label preliminary trial","volume":"90","author":"Van Thiel DH","year":"1995","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"e_1_2_14_86_2","article-title":"Low dose tacrolimus as treatment of severe autoimmune hepatitis: potential role in remission induction","volume":"44","author":"Heneghan MA","year":"1999","journal-title":"Gut"},{"key":"e_1_2_14_87_2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v13.i23.3232"},{"key":"e_1_2_14_88_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.mcg.0000139050.67178.be"},{"key":"e_1_2_14_89_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(05)80615-4"},{"key":"e_1_2_14_90_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1999.00807.x"},{"key":"e_1_2_14_91_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2003.01754.x"},{"key":"e_1_2_14_92_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(99)70339-2"},{"key":"e_1_2_14_93_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(99)80065-8"},{"key":"e_1_2_14_94_2","first-page":"571","article-title":"Cyclophosphamide as alternative immunosuppressive therapy for autoimmune hepatitis \u2013 report of three cases","volume":"35","author":"Kanzler S","year":"1997","journal-title":"Z Gastroenterol"},{"key":"e_1_2_14_95_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(98)80128-1"},{"key":"e_1_2_14_96_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2006.01262.x"},{"key":"e_1_2_14_97_2","doi-asserted-by":"publisher","DOI":"10.1080\/09546630500424722"},{"key":"e_1_2_14_98_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2005.00801.x"},{"key":"e_1_2_14_99_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510300603"},{"key":"e_1_2_14_100_2","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2002.30902"},{"key":"e_1_2_14_101_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2005.41841.x"},{"key":"e_1_2_14_102_2","first-page":"162","article-title":"Azathioprine and the liver. Evidence favoring idiosyncratic, mixed cholestatic\u2010hepatocellular injury in humans","volume":"86","author":"De Pinho RA","year":"1984","journal-title":"Gastroenterology"},{"key":"e_1_2_14_103_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840030510"},{"key":"e_1_2_14_104_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840040409"},{"key":"e_1_2_14_105_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2004.30457.x"},{"key":"e_1_2_14_106_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(00)00095-7"},{"key":"e_1_2_14_107_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840110621"},{"key":"e_1_2_14_108_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.32.2.202"},{"key":"e_1_2_14_109_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.48.1.97"},{"key":"e_1_2_14_110_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2006.00479.x"},{"key":"e_1_2_14_111_2","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0b013e318176b8c5"},{"key":"e_1_2_14_112_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(05)80005-4"},{"key":"e_1_2_14_113_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.1996.v110.pm8608895"},{"key":"e_1_2_14_114_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1746.2001.02615.x"},{"key":"e_1_2_14_115_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2006.03104.x"},{"key":"e_1_2_14_116_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2008.05365.x"},{"key":"e_1_2_14_117_2","first-page":"52","article-title":"Autoimmune Hepatitis: effect of symptoms and cirrhosis on natural history and outcome","volume":"42","author":"Feld JJ","year":"2005","journal-title":"Hepatology"},{"key":"e_1_2_14_118_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(88)90503-3"},{"key":"e_1_2_14_119_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1746.2003.03165.x"},{"key":"e_1_2_14_120_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2008.08.018"},{"key":"e_1_2_14_121_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22432"},{"key":"e_1_2_14_122_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2008.01922.x"},{"key":"e_1_2_14_123_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510260508"},{"key":"e_1_2_14_124_2","doi-asserted-by":"publisher","DOI":"10.1002\/lt.20137"},{"key":"e_1_2_14_125_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.52.6.893"},{"key":"e_1_2_14_126_2","doi-asserted-by":"publisher","DOI":"10.1002\/lt.20910"},{"key":"e_1_2_14_127_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2567.2003.01678.x"},{"key":"e_1_2_14_128_2","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1182\/blood-2004-01-0086","article-title":"Large\u2010scale in vitro expansion of polyclonl human CD4(+)CD25 high regulatory T cells","volume":"104","author":"Hoffman P","year":"2004","journal-title":"Blood"},{"key":"e_1_2_14_129_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22071"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2010.04241.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2036.2010.04241.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T09:44:55Z","timestamp":1698745495000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2036.2010.04241.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3,17]]},"references-count":128,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["10.1111\/j.1365-2036.2010.04241.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2036.2010.04241.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"type":"print","value":"0269-2813"},{"type":"electronic","value":"1365-2036"}],"subject":[],"published":{"date-parts":[[2010,3,17]]}}}